Clobazam Suspension
Product Images NDC 62135-527

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 62135-527). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chartwell Rx, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle-label (Clobazam Container Label)

Label for Clobazam Oral Suspension containing 2.5 mg/mL of the active ingredient. The product is prescription only and comes in a 120 mL bottle. Labeler is Chartwell RX, LLC, and the label includes storage, usage instructions, and safety warnings. The label features a barcode and mentions 'No Varnish'.*

FDA Label Image

Clobazam-figure-1 (Clobazam Figure 1)

A bar chart showing percent reduction in weekly drop seizure rate across four groups: Placebo, Low, Medium, and High doses. The Placebo group shows a -12.1% reduction, Low dose -41.2%, Medium dose -49.4%, and High dose -68.3%. Statistical significance markers indicate p < 0.05 for Low and High groups, and p < 0.01 for Medium group.*

FDA Label Image

Clobazam-figure-2 (Clobazam Figure 2)

A bar chart showing the proportion of patients (%) by their reduction in weekly drop seizure frequency from baseline (%) comparing placebo and three Clobazam dosage levels: low, medium, and high. The x-axis represents percentage ranges of seizure reduction (Worse, 0 to <20, 20 to <40, 40 to <60, 60 to <80, 80 to 100). The y-axis shows the proportion of patients in each category.*

FDA Label Image

Clobazam-figure-a (Clobazam Figure A)

An instructional illustration showing two hands opening a bottle by twisting the cap, demonstrating the proper way to open a medication bottle for oral suspension.*

FDA Label Image

Clobazam-figure-b (Clobazam Figure B)

An illustration showing a hand using a syringe to withdraw liquid from a bottle, demonstrating proper technique for drawing oral suspension medication from the bottle.*

FDA Label Image

Clobazam-figure-c (Clobazam Figure C)

An instructional illustration showing hands drawing oral suspension liquid from a bottle into a syringe, with an arrow indicating upward movement to fill the syringe. It demonstrates the correct method for measuring Clobazam suspension orally.*

FDA Label Image

Clobazam-figure-d (Clobazam Figure D)

An instructional drawing showing a person drawing liquid medication from a bottle using a syringe. The image depicts hands holding the bottle and syringe, with an upward arrow indicating the syringe is being pulled to draw the suspension liquid from the bottle.*

FDA Label Image

Clobazam-structure-formula.jpg (Clobazam Structure Formula)

Chemical structure of Clobazam, showing its molecular arrangement with a chlorinated benzodiazepine core structure and associated functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.